Carbon Monoxide Urban Air Pollution: Cardiac Effects by Meyer, G. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Carbon Monoxide Urban Air 
Pollution: Cardiac Effects 
G. Meyer , S. Tanguy, P. Obert and C. Reboul  
Laboratory of Cardiovascular Pharm-ecology,  
Faculty of Sciences, Avignon University, 
France 
1. Introduction 
Heart disease is a leading cause of death world-wide. The development of heart 
pathological phenotype results from a complex interplay between genetic and 
environmental factors. Among environmental factors, recently the deleterious health effects 
of urban air pollution were pointed out in epidemiological studies (Bhatnagar, 2006, Brook 
et al., 2004) and a particular attention is then paid to micro and nano-particles air pollution. 
However, some gazes, such as SO2, NOx, O3, COx, could also be reported to have potential 
deleterious cardiovascular health effects. Particularly, carbon monoxide (CO) resulting from 
the partial oxidation of carbon-containing compound is reported in epidemiological studies 
as one of the main pollutants responsible for the development of cardiovascular diseases 
(Bell et al., 2009, Stieb et al., 2009). Indeed, at low concentration, as may be found in urban 
environment, CO has been correlated with hospital admissions, mortality and morbidity 
related to cardiovascular dysfunctions (Bell et al., 2009, Burnett et al., 1997).  
Today, the cardiac effects of CO poisoning, corresponding to acute exposure to very high 
concentrations of CO (1000 – 10000 ppm), were largely studied and are known as the 
consequence of tissue hypoxemia resulting from the high affinity of CO for blood 
haemoglobin. However, at low concentrations, as classically found in urban environment, 
such a hypoxemia could not be considered as a trigger of CO-induced cardiac incoherencies. 
Then, although some epidemiological evidences that CO air pollution could play a key role 
in the deleterious effects of prolonged exposure to urban air pollution, today, whether this 
gaze could be considered as a main risk factor in the development of cardiac diseases, is less 
understood. Therefore, the aim of this review was to explore, based on experimental 
literature, the potential link between exposure to such an environmental pollutant and 
occurrence of cardiac disturbances. 
2. CO in urban environment 
The purpose of this review is not to discuss on the level of CO measured in urban area. 
However, in order to focus our review on concentrations corresponding to those measured 
in urban environment, we first have to consider the range of urban CO concentration 
observed in environmental studies.  
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In urban area the most common sources of CO are cigarette smoke and vehicle exhaust 
(Cunnington and Hormbrey, 2002). In the US, daily mean ambient levels of CO range from 
0.5 to 2 ppm (Samet et al., 2000). Exhaled CO levels range from 0 to 21 ppm in non smokers, 
and from 2 to 50 ppm in smokers (Jones and Lam, 2006). The highest levels of CO exposure 
were found in car park/garages (12 ppm), private car/taxi (11 ppm) and bar/pub/nights 
club (8 ppm) (Chau et al., 2002). Then, in urban environments CO concentration usually 
varies from 2 to 40 ppm, but during heavy traffic or when peoples are exposed to second-
hand cigarette smoke it may be as high as 170 ppm (Bevan, 1991, Stern et al., 1988, Wright et 
al., 1975). Although CO levels are relatively low in urban environment, data from the 
APHEA-2 project (Air Pollution and Health: A European Approach) studying the relation 
between air pollution and total cardiovascular mortality in 19 European cities, reported a 
significant association of CO with cardiovascular mortality (Samoli et al., 2007). 
3. Regular exposure to low CO level and phenotypical remodelling of the 
heart 
3.1 Acute low level CO exposure 
The acute effects of such low levels of CO on the myocardium are today few studied and 
results are contradictory and conflicting. Thom et al., (Thom et al., 1999, Thom et al., 2000) 
discussed that carboxyhemoglobin (HbCO) values associated with levels of CO found in 
urban area are so low that tissue hypoxemic stress is doubtful and compensatory 
physiological mechanisms certainly are sufficient to maintain tissue oxygenation. These 
authors reported yet, on cultured endothelial cells, that acute exposure to low 
concentrations of CO cause a nitric oxide (NO)-dependent oxidative stress, since CO 
deleterious effects were inhibited by the addition of Nɷnitro-L-arginine methyl ester to 
inhibit NO synthesis (Thom et al., 2000). In this study, the reaction of NO with superoxide 
anion to form the highly cytotoxic peroxynitrite is mentioned as a main trigger of lethal CO 
effects. Indeed, it is today well established that acute CO exposure was associated with 
higher reactive oxygen species production (Piantadosi, 2002). Indeed, CO molecules form 
relatively tight complexes with heme proteins (instead of O2) responsible for mitochondrial 
and non-mitochondrial reactive oxygen species production (Piantadosi, 2008). Regarding its 
mitochondrial effects, it was shown that CO binds to cytochrome-c-oxidase altering 
mitochondrial electron transport chain and then, especially in metabolically active tissues 
like heart, induced reactive oxygen species production (D'Amico et al., 2006, Zuckerbraun et 
al., 2007). CO-dependent reactive oxygen species production could also occur via non-
mitochondrial sources, notably NADPH oxidase and nitric oxide synthase (NOS) 
(Piantadosi, 2008); however this is not yet clearly established in the scientific literature.  
During CO exposure, the interaction between reactive oxygen species and NO, mentioned 
above, could also contribute to alter the regulation of coronary blood flow and then the 
regulation of myocardial perfusion. Indeed, it is today well known that NO play a major role 
in the coronary vasomotor response of the myocardium. Therefore, we can note that a 
myocardial dysfunction and a potential cardiac hypoxia in heart of rats inhaling CO for 90 min 
at 250 ppm was previously reported (Favory et al., 2006). In this model, myocardial hypoxia 
was explained by coronary endothelium dependent abnormalities. Such a coronary-dependent 
impairment of myocardial perfusion could then contribute to exacerbate tissue hypoxia. 
3.2 Prolonged low level CO exposure 
CO molecule, promoting reactive oxygen species dependent signalling molecules, could 
have biological significance in the adaptation of cells to hypoxia. However, whether 
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recurrent exposure to low levels of CO could participate to the deleterious effects of urban 
CO exposure is not today well understood. Recently, Bye et al. (Bye et al., 2008) reported, in a 
model of rats exposed to CO levels experienced by heavy smokers (18 months, 5 days a week 
at 200 ppm), a pathological remodelling of the heart, characterized by impaired Ca2+ handling 
and increased growth factor signalling. This pathological hypertrophy of the heart was 
associated in-vivo with reduced aerobic capacity. In model simulating CO exposure at level 
found in cigarette smoke (200 ppm for 14 consecutive days), the use of LU135252, a selective 
inhibitor of type A endothelin (ET-1) receptors (ETA), in drinking water, markedly prevents 
right ventricular hypertrophy but not left ventricular, suggesting then a role of ET-1 in the 
right ventricle and/or in the pulmonary circulation during CO exposure (Loennechen et al., 
2002). In another model, closer to urban area pollution, Andre et al. (Andre et al., 2010) 
reported that 4 weeks of CO exposure at low levels (30-100 ppm 12 hours/day) in healthy rats, 
promotes heart arrhythmias, even in absence of CO in the environment. This propensity was 
exacerbated during a β-adrenergic stress. This phenomenon is explained in this work by a 
pathological cardiomyocytes remodelling. Indeed, in this model of rats, following 4 weeks of 
CO exposure at low level, both contraction and relaxation of single cardiomyocytes were 
altered. Several changes explained this alteration of cells function, including decreased Ca2+ 
transient amplitude, decreased Ca2+ sensitivity of myofilaments and increased diastolic 
intracellular Ca2+ subsequent to reduced SERCA-2a expression and increased Ryanodine 
receptor (RyR) phosphorylation (on the PKA-dependent site Ser2809). Authors evoked β-
adrenergic stress as a potential trigger of this phenotypical cardiac myocytes remodelling. 
Indeed, at the cardiomyocytes level, β-adrenergic stimulation activates PKA, which 
phosphorylates both Ca2+ handling proteins involved in excitation-contraction-coupling and 
myofilaments regulatory proteins. This hypothesis is endorsed by the lower β-adrenergic 
response in animals exposed to CO pollution. Because reactive oxygen species could also 
activate PKA in the heart (Marx et al., 2000) and CO is well known to activate reactive oxygen 
species production, the authors also hypothesized that oxidative stress could be a main trigger 
of this specific remodelling. This is supported by the impairment of heart enzymatic 
antioxidant status in CO exposed rat hearts and increased activity of thioredoxin reductase 
confirming then, in this model, that CO, even at very low levels, was responsible for heart 
oxidative stress. Finally, prolonged CO exposure (50 ppm during 3 weeks) in rats with 
pathological right ventricular hypertrophia was reported to induce RV tissue necrosis (Gautier 
et al., 2007). The authors reported then, that CO-induced alteration of the right ventricular 
perfusion could play a key role in this phenomenon.  
4. Prolonged low level CO exposure and ischemic pathology of the heart 
Myocardial infarction due to ischemia reperfusion remains today a major cause of morbidity 
and mortality in western nations. Those myocardial ischemia-reperfusion injuries result in 
cardiac dysfunction, arrhythmias, as well as irreversible myocytes damages (Murphy and 
Steenbergen, 2008). Sensitivity of the myocardium to ischemia-reperfusion-induced cellular 
injuries is recognized today to be the result of a complex interplay between genetic, 
pathological and environmental factors.  
4.1 Acute CO exposure and Ischemic pathology of the heart 
Regarding ischemic pathologies of the heart the effect of CO is today still controversial. 
Indeed, CO is classically used to pre-condition the heart and then reduce its vulnerability 
against ischemia-reperfusion (Clark et al., 2003, Fujimoto et al., 2004, Stein et al., 2005). 
Indeed, since the study of Clark et al. (Clark et al., 2003) has reported the cardioprotective 
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effects of a water soluble CO releasing molecule, named CORM-3, many studies tested 
whether CORM-3 or acute CO exposure could reduce the severity of myocardial ischemia-
reperfusion injuries. Today, CORM-3 is known as reducing the severity of ventricular 
fibrillation (Bak et al., 2003) and the size of infracted area (Clark et al., 2003) without altered 
HbCO concentration (Guo et al., 2004). In the same way, exogenous CO in perfusion buffer 
of isolated heart (0.01 or 0.001%) was reported to improve myocardial post-ischemic 
recovery (Bak et al., 2005). Finally, acute inhaled CO exposures (from few hours to 24 hours) 
at high levels (from 500 to 1000 ppm) were reported to be able to precondition the heart 
against such a coronary artery occlusion (Fujimoto et al., 2004). P38 mitogen activated 
protein kinase (p38MAPK) and akt-eNOS-GMPc pathway were reported to be mainly 
implicated in this cardioprotective effects of inhaled CO.  
4.2 Prolonged CO exposure and ischemic pathology of the heart 
All in all, those results mainly suggest that CO possesses some cardioprotective properties. 
However, this is not in accordance with numerous epidemiological studies reporting the 
potential toxicological properties of this gas in air pollution (see above). In addition, it was 
reported in some experimental models, that regular exposure to environmental tobacco 
smoke, in which CO is one of the main toxic components (CO concentration about 90 ppm), 
increases infarct size (Zhu et al., 1996, Zhu et al., 1994). Finally, the pathologic phenotypical 
remodeling of heart contractile cells, as mentioned above, could be taken to suggest that 
prolonged CO exposure could deleteriously influence heart vulnerability to ischemia-
reperfusion. Then, in regard to this phenotypical remodelling of cardiomyocytes, some 
authors were recently interested in evaluating the influence of prolonged CO exposure on 
heart sensitivity to ischemia-reperfusion, and the potential link between regular exposure to 
CO and mortality from cardiac incoherencies during such an ischemic stress. In such 
experimental work, prolonged CO exposure, simulating urban environmental pollution (30-
100 ppm 12 hours/day), was reported to exacerbate rat heart ischemia-reperfusion injuries 
(Figure 1) (Meyer et al., 2010). This higher vulnerability was characterized in CO rats’ 
myocardium by i) lower recovery of myocardial function and coronary blood flow during 
post-ischemic reperfusion, ii) higher severity of reperfusion arrhythmias, characterized 
notably by higher propensity of ventricular fibrillation, and iii) higher infarct size and cells 
death. This phenomenon is mainly explained in this study by exacerbated oxidative stress. 
Indeed, increased lipid peroxidation was measured in heart of CO exposed rats after 30 min 
of reperfusion. This could be logically explained by reduced enzymatic antioxidant defence 
capacities reported in CO rats’ myocardium. Then, it is of interest to note that in this work, 
at cardiomyocyte level, an antioxidant strategy (N-Acetyl-Cysteine infusion) during anoxia-
reoxygenation, was able to normalize post-ischemic functional recovery in CO rat heart cells 
(evaluated by sarcomere length shortening). These effects seem to be mediated by a 
normalization of cytosolic Ca2+ concentrations. In the same way, in another study, the 
authors evaluated whether, a cardioprotective strategy, such as exercise, was able to prevent 
the deleterious effects of CO exposure on cardiomyocytes phenotypical remodelling and 
then influences heart sensitivity to ischemia-reperfusion (Farah et al., 2010). In this work, it 
is reported that moderate exercise, specifically designed to follow the recommendation of 
the World Health Organisation, conducted 4 weeks before CO exposure and all along CO 
exposure period, prevented the pathological remodelling of the heart, including 
normalization of myocardial antioxidant status and Ca2+ handling. The last result could be 
notably explained by beneficial effects of exercise training on SERCA-2a expression which 
restored intra-cellular Ca2+ homeostasis. Finally, a main result of this work was that this 
strategy markedly reduced the vulnerability of CO rat hearts to ischemia-reperfusion. 
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Fig. 1. Potential mechanisms involved in chronic low level CO exposure-induced increased 
cardiac sensitivity to ischemic stress.  
Potential mechanisms involved in chronic low level CO exposure-induced increased cardiac 
sensitivity to ischemic stress. This figure summarize how as a result of CO effects, the 
cardiovascular system developed a pathological phenotype which renders the heart more 
sensitive to myocardial infarction. 1: CO ability to bound to heme proteins lead to an increased 
ROS production; 2: The activation of ROS production associated with reduced antioxidant 
enzyme defences result in significant CO-induced oxidative stress, leading then to contractile 
dysfunction and higher occurrence of ventricular arrhythmias; 3: CO induced potential 
production of superoxide anion instead of NO (eNOS uncoupling) reduced NO bioavailability. 
This could lead to coronary artery endothelium dysfunction and then to myocardial 
hypoxemia; 4: Ca2+ handling play a major role in excitation-contraction coupling. Although 
today there is no evidence for direct CO effects on Ca2+ handling proteins, it is recently 
demonstrated that prolonged CO exposure markedly altered Ca2+. This could be mediated by 
CO-induced ROS production; 5: Probably as a stress signalling pathway, CO induced an 
increased endothelin (ET-1) production leading then to heart remodelling. 
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Today, among environmental pollutants, CO is less considered, notably because of its very 
low concentration in urban environment. However, today, such a review of the experimental 
literature points out that, even at very low concentrations that can be found in urban 
environment, CO has potential high toxicological properties, and the heart appears to be 
particularly sensitive to this gas. Indeed, despite during in-vivo experiments, at the integrated 
level, prolonged CO exposure has no major consequence on healthy heart, and induced only 
modest adaptations with no apparent fatal issue, at the cellular level, those modest events and 
adaptations hide a compensated pathological remodelling of cardiomyocytes phenotype. 
Then, one of the main assessments of the present review is that prolonged exposure to low CO 
level results in a compensated phenotypical remodelling which could render the heart more 
vulnerable to stress and more particularly to pathological stresses. Therefore, among the 
numerous environmental air pollutants, exposure to CO pollution seems to be an important 
risk factor for the development of cardiovascular pathologies. 
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